Between 2015 and 2023, total pharmaceutical spending in Brazil displayed minimal annual fluctuations, remaining around 18.18-18.25 units of health expenditure. The year-on-year variations are generally minor, with the largest decline in 2017 (-1.57%). CAGR for most years is marginal, indicating a stable expenditure pattern with an average decline of -0.043% in 2023 over the last five years. As of 2023, the expenditure is at 18.18 units. Forecasts suggest a slight decline, reaching 18.17 units in 2028, projecting a -0.01% CAGR and a -0.05% forecast growth rate over the next five years.

Future trends to watch for include:

Potential impacts of emerging healthcare technologies and digital health solutions.
Government healthcare policies and reforms which may influence pharmaceutical spending.
Economic factors such as inflation and currency fluctuations impacting overall expenditure.